SCHEMBL6894926

SCHEMBL6894926

CCCCCCCCCCCCCCCCCCCCCC(C)=O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CES2 O00748 4/20 0.65
▸ CES1 P23141 4/20 0.65
▸ GPR84 Q9NQS5 7/20 0.62
▸ PPARG P37231 7/20 0.62
▸ PPARD Q03181 7/20 0.62
▸ PPARA Q07869 7/20 0.62
▸ HDAC11 Q96DB2 5/20 0.62
▸ TSHR P16473 5/20 0.62
▸ PTPN1 P18031 3/20 0.62
▸ ALDH1A1 P00352 3/20 0.62
▸ TLR2 O60603 2/20 0.62
▸ TDP1 Q9NUW8 2/20 0.62
▸ FABP4 P15090 2/20 0.62
▸ SLC22A6 Q4U2R8 1/20 0.62
▸ SLC22A8 Q8TCC7 1/20 0.62
▸ MEN1 O00255 1/20 0.62
▸ ESR1 P03372 1/20 0.62
▸ ALOX15 P16050 1/20 0.62
▸ PDE4A P27815 1/20 0.62
▸ KMT2A Q03164 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2-Nonanone SCHEMBL4485770 1.00 CES2 (0.65) CES2CES1GPR84PPARGPPARD
2-Tridecanone SCHEMBL119126 1.00 CES2 (0.65) CES2CES1GPR84PPARGPPARD
2-Nonanone SCHEMBL4562318 1.00 CES2 (0.65) CES2CES1GPR84PPARGPPARD
2-Tridecanone SCHEMBL19838551 1.00 CES2 (0.65) CES2CES1GPR84PPARGPPARD
SCHEMBL24005728 1.00 CES2 (0.65) CES2CES1GPR84PPARGPPARD
2-Dodecanone SCHEMBL23501396 1.00 CES2 (0.65) CES2CES1GPR84PPARGPPARD
SCHEMBL43776 1.00 — —
SCHEMBL7618683 1.00 CES2 (0.65) CES2CES1GPR84PPARGPPARD
SCHEMBL21044722 1.00 CES2 (0.65) CES2CES1GPR84PPARGPPARD
SCHEMBL11144661 1.00 CES2 (0.65) CES2CES1GPR84PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112457277-B Preparation method of tafluprost 西安国康瑞金制药有限公司 2022-06-28 — — CN claimed
EP-3634133-A1 METHOD FOR SELECTING BEE COLONIES HAVING THE VSH TRAIT AND COMPOSITION AND KIT FOR IMPLEMENTING SAME Institut National de la Recherche Agronomique (FR) 2020-04-15 — — EP claimed
WO-2018224765-A1 METHOD FOR SELECTING BEE COLONIES HAVING THE VSH TRAIT AND COMPOSITION AND KIT FOR IMPLEMENTING SAME INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) 2018-12-13 — — WO claimed
JP-2003500452-A — — 2003-01-07 — — JP claimed
EP-1183039-A1 PHARMACEUTICAL PREPARATIONS OF BIOACTIVE SUBSTANCES EXTRACTED FROM NATURAL SOURCES Armadillo Pharmaceuticals, Inc. (US) 2002-03-06 — — EP claimed
WO-2000072861-A1 PHARMACEUTICAL PREPARATIONS OF BIOACTIVE SUBSTANCES EXTRACTED FROM NATURAL SOURCES ARMADILLO PHARMACEUTICALS, INC. (US) 2000-12-07 — — WO claimed
US-12534688-B2 Fabric softener composition comprising a betaine ester and a fatty co-softener CONOPCO, INC. (US) 2026-01-27 — — US disclosed
US-12522560-B2 Quaternary ammonium compounds SPECIALTY OPERATIONS FRANCE (FR) 2026-01-13 — — US disclosed
US-20250388820-A1 RECYCLE OF C4- OR C6- LIGHT HYDROCARBON LIQUIDS TO ACID CONDENSATION FEED JOHNSON MATTHEY PLC (GB) 2025-12-25 — — US disclosed
US-20250388524-A1 RECOVERY OF C4+ HYDROCARBONS FROM ACID CONDENSATION PRODUCT JOHNSON MATTHEY PLC (GB) 2025-12-25 — — US disclosed
US-20250387785-A1 USE OF CARBON DIOXIDE AND OXYGEN IN THE REGENERATION OF THE ACID CONDENSATION CATALYST JOHNSON MATTHEY PLC (GB) 2025-12-25 — — US disclosed
US-20250388821-A1 TEMPERATURE CONTROL FOR ACID CONDENSATION JOHNSON MATTHEY PLC (GB) 2025-12-25 — — US disclosed
US-20250388818-A1 REDUCTION OF ACID CONDENSATION CATALYST COKE YIELD BY SELECTIVE VAPORIZATION OF THE HYDRODEOXYGENATION HEAVIES STREAM JOHNSON MATTHEY PLC (GB) 2025-12-25 — — US disclosed
WO-2018224765-A1 METHOD FOR SELECTING BEE COLONIES HAVING THE VSH TRAIT AND COMPOSITION AND KIT FOR IMPLEMENTING SAME INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) 2018-12-13 — — WO disclosed
EP-3118621-A1 METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND FOR THE TREATMENT OF ADRENOLEUKODYSTROPHY Fundació Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) (ES) 2017-01-18 — — EP disclosed
US-20160174603-A1 Electronic Vapor Liquid Composition and Method of Use INNOVATIVE HERBAL BLENDS, LLC 2016-06-23 — — US disclosed
US-6746695-B1 DISRUPTING PLANT MATERIAL COMPRISING KAVA ROOT, CONTACTING WITH SUPERCRITICAL FLUID OF ISOPROPYL AMINE, CARBON DIOXIDE AND AN ALCOHOL, COLLECTING WITH RESIN TRAP, ELUTING BYSUPERCRITICAL FLUID CHROMATOGRAPHY ARMADILLO PHARMACEUTICALS, INC. 2004-06-08 — — US disclosed
EP-1183039-A1 PHARMACEUTICAL PREPARATIONS OF BIOACTIVE SUBSTANCES EXTRACTED FROM NATURAL SOURCES Armadillo Pharmaceuticals, Inc. (US) 2002-03-06 — — EP disclosed
WO-2000072861-A1 PHARMACEUTICAL PREPARATIONS OF BIOACTIVE SUBSTANCES EXTRACTED FROM NATURAL SOURCES ARMADILLO PHARMACEUTICALS, INC. (US) 2000-12-07 — — WO disclosed
EP-0624563-A1 Glycerin derivatives and process for producing the same KAO CORPORATION (JP) 1994-11-17 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250387785-A1 USE OF CARBON DIOXIDE AND OXYGEN IN THE REGENERATION OF THE ACID CONDENSATION CATALYST HAO2, SCO2, HMOX2 CES2 2762/4885CES1 2655/4885GPR84 3516/4885
US-20250388524-A1 RECOVERY OF C4+ HYDROCARBONS FROM ACID CONDENSATION PRODUCT SCO2, ACACB, ACACA CES2 1697/4885CES1 1089/4885GPR84 3490/4885
US-20250388818-A1 REDUCTION OF ACID CONDENSATION CATALYST COKE YIELD BY SELECTIVE VAPORIZATION OF THE HYDRODEOXYGENATION HEAVIES STREAM HAO2, SCO2, HAAO CES2 2420/4885CES1 1763/4885GPR84 2467/4885
US-20250388821-A1 TEMPERATURE CONTROL FOR ACID CONDENSATION HAO2, HAO1, HAAO CES2 1807/4885CES1 1736/4885GPR84 3469/4885
US-12534688-B2 Fabric softener composition comprising a betaine ester and a fatty co-softener COL2A1, LBR, YWHAZ CES2 552/4885CES1 51/4885GPR84 1128/4885
US-20250388820-A1 RECYCLE OF C4- OR C6- LIGHT HYDROCARBON LIQUIDS TO ACID CONDENSATION FEED RER1, C9, C1S CES2 1553/4885CES1 895/4885GPR84 3078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback